Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital

NCT04959643 | Unknown

• 1 other identifier: RECHMPL20_0439 -UF-8029
• Study Type: observational
• Target: 600
• Locations: 1 country
• Sites: 1

Brief Summary

A high number of people are infected by viral hepatitises B and C without knowing it, especially vulnerable population such as the ones who come in consultation in continuous health care access center (Permanence d'accès aux soins, PASS). Now that these infections can be rapidly treated, it is essential to diagnose them the quickest possible. The Identification and Diagnostic Orientation Test (Test de repérage et d'orientation diagnostique, TROD) technique is a rapid tool allowing to screen for hepatitis B and C by a simple capillary sample. The study aims to evaluate the accptability of a systematic screening using TROD for hepatitis B and C in adults in a PASS consultation in Montpellier. We also want to estimate the prevalence of theses infections in the population, to describe the HBV and HCV care cascades, to evaluate the acceptability of vaccinal catch-up for HBV, and to describe people with hepatits.

Conditions

Hepatitis C; Hepatitis B; Addiction

Keywords

Hepatitis; Viral hepatitis; Hepatitis B; Hepatitis C; Addiction; Rapid orientation tool; TROD; Continuous health care center; PASS

Outcome Measures

Primary Outcomes (1)

• Rate of performed TROD

  Proportion of performed TROD out on the number of people it has been offered.

  Inclusion visit

Secondary Outcomes (21)

• Prevalence of hepatits B in the population

  Inclusion visit

• Prevalence of hepatits C in the population

  Inclusion visit

• Care Cascade for HBV

  3 months

• Care Cascade for HCV

  6 months

• Age

  Inclusion visit

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adults in Montpellier's PASS consultation

You may qualify if:

• People of 18 years old and more
• Non objection to be a participant of the study

You may not qualify if:

• Judicial protection (sauvegarde de justice, tutelle or curatelle)
• Impossibility of offering clear information to the subject

Sponsors & Collaborators

• University Hospital, Montpellier: lead
• Gilead Sciences: collaborator

Study Sites (1)

CHU Montpellier, St Eloi Hospital,

Montpellier, Hérault, 34295, France

RECRUITING

MeSH Terms

Conditions

Hepatitis C; Hepatitis B; Behavior, Addictive; Hepatitis

Condition Hierarchy (Ancestors)

Blood-Borne Infections; Communicable Diseases; Infections; Hepatitis, Viral, Human; Virus Diseases; Flaviviridae Infections; RNA Virus Infections; Liver Diseases; Digestive System Diseases; Hepadnaviridae Infections; DNA Virus Infections; Compulsive Behavior; Impulsive Behavior; Behavior

Study Officials

• Helene DONNADIEU RIGOLE, MH PD

  Biochemistry department

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Helene DONNADIEU RIGOLE

CONTACT

MH PD; h-donnadieu_rigole@chu-montpellier.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 18, 2021
• First Posted: July 13, 2021
• Study Start: October 5, 2021
• Primary Completion: July 1, 2023
• Study Completion: October 1, 2023
• Last Updated: January 10, 2022

Record last verified: 2021-10

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)